ResearchDx/Targeted Genomics receives FDA 510 (k) Clearance!
ResearchDx and Targeted Genomics are thrilled to announce that the GlutenID Celiac Genetic Health Risk Test has received FDA 510(k) clearance (K241456) with testing to be performed at ResearchDx’s PacificDx facility. Press Release Decision Summary
HistoIndex
FibroSIGHT™ is Here: A New Standard in Clinical Care of MASH Patients Read More
ResearchDx/Targeted Genomics receives FDA 510 (k) Clearance!
ResearchDx and Targeted Genomics are thrilled to announce that the GlutenID Celiac Genetic Health Risk Test has received FDA 510(k) clearance (K241456) with testing to be performed at ResearchDx’s PacificDx facility. Press Release Decision Summary